| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 7.442 | 29.963 | 26.461 | 14.384 | 22.111 | 22.041 |
| Total Income - EUR | - | - | - | - | 7.442 | 29.963 | 26.461 | 14.384 | 22.111 | 22.041 |
| Total Expenses - EUR | - | - | - | - | 7.079 | 24.255 | 22.637 | 15.191 | 21.782 | 24.209 |
| Gross Profit/Loss - EUR | - | - | - | - | 363 | 5.708 | 3.823 | -807 | 329 | -2.168 |
| Net Profit/Loss - EUR | - | - | - | - | 140 | 4.858 | 3.046 | -1.174 | -55 | -2.168 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Fevi Gyn S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 49 | 1.760 | 1.092 | 464 | 0 | 481 |
| Current Assets | - | - | - | - | 2.388 | 3.715 | 4.473 | 998 | 1.564 | 6.233 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 307 |
| Cash | - | - | - | - | 2.388 | 3.715 | 4.473 | 998 | 1.564 | 5.927 |
| Shareholders Funds | - | - | - | - | 182 | 5.036 | 3.106 | 949 | -6 | -2.174 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 2.255 | 439 | 2.458 | 514 | 1.571 | 8.888 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Fevi Gyn S.r.l.